Histogen Inc. (CPH.F)
| Previous Close | 0.7290 |
| Open | 0.7860 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's Range | 0.7290 - 0.8150 |
| 52 Week Range | 0.4515 - 1.5500 |
| Volume | |
| Avg. Volume | 287 |
| Market Cap | 3.114M |
| Beta (5Y Monthly) | 1.17 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.1500 |
| Earnings Date | Apr 19, 2024 - Apr 22, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireHistogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO, the “Company” or “Histogen”), a drug development company for treatment of bacterial skin infections, today announced that it has filed voluntary petitions for relief under subchapter V of Chapter 11 of the U.S. Bankruptcy Code (“Chapter 11”) in the United States Bankruptcy Court for the Southern District of California to confirm a plan of liquidation that will distribute all value to stakeholders, including shareholders. Histogen
GlobeNewswireHistogen Announces Second Adjournment of Special Meeting of Stockholders
Histogen Special Meeting QR Code Histogen Special Meeting QR Code Meeting Adjourned for a Final Time to January 4, 2024 at 8:00 a.m. PTPotential Estimated Cash Distribution to Shareholders of $0.30 to $0.41 if Dissolution Proposal Approved SAN DIEGO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (OTC: HSTO), today announced that its special meeting of stockholders (the “Special Meeting”) has been adjourned to Thursday, January 4, 2024 at 8:00 a.m. Pacific Time with respect to both proposals de
- GlobeNewswire
Histogen Announces Adjournment of Special Meeting of Stockholders
Meeting Adjourned to December 14, 2023 at 8:00 a.m. PT Histogen Special Meeting QR Code Histogen Special Meeting QR Code SAN DIEGO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (OTC: HSTO) today announced that its special meeting of stockholders (the “Special Meeting”) has been adjourned to Thursday, December 14, 2023 at 8:00 a.m. Pacific Time with respect to both proposals described in its definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on Octobe
